We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Leading Expert On U.S. Health Reform Gives His Two Cents
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Health Reform > Leading Expert On U.S. Health Reform Gives His Two Cents
BusinessHealth Reform

Leading Expert On U.S. Health Reform Gives His Two Cents

HerinaAyot
HerinaAyot
Share
3 Min Read
SHARE

Paul Keckley noted that things may get worse before they get better in the healthcare and lifescience industry in the United States. The Executive Director of The Deloitte Center for Health Solutions, the healthcare research arm for Deloitte LLP., was the luncheon keynote speaker at this year’s OneMedForum NY 2011.

Paul Keckley noted that things may get worse before they get better in the healthcare and lifescience industry in the United States. The Executive Director of The Deloitte Center for Health Solutions, the healthcare research arm for Deloitte LLP., was the luncheon keynote speaker at this year’s OneMedForum NY 2011.

With the recent decrease of the FDA’s funding by 11 percent, those bringing new drugs and devices to market will expect to pay a substantially higher fee for approvals through the FDA and the efficiency of the FDA in the approval process is questionable.  In addition, Keckley notes that information driven healthcare may be completely integrated within five to seven years. Healthcare and lifescience research will be captured in a research depository database. FDA studies around safety and efficacy will be put in that same database along with medical records from doctors and hospitals and records from those individuals covered by government insurance programs.

The program aims to bring together cost and equality and address what works and how much it costs. Keckley does not expect the series of laws called healthcare reform to be repealed, but does expect substantial pressure on margins, greater transparency of trial results, and full disclosure of failed trials. Considering the decade it will take for the laws to be implemented and the four election cycles that will transpire in that time, Keckley believes changes are inevitable.

More Read

Medical Device Marketing, Digital Marketing, Slideshare, Hubspot
Is a Slide Presentation a Worthy Medical Device Marketing Tool?
Path Dependency in Health Reform: The Case of Medicare
Cost Spotlight: A 443% Markup on Prescription Drugs
Is Europe A Better Place To Build A Medical Technology Company?
How Increasing Medicare Age of Eligibility Saves Under Reform

On the horizon, he sees a substantial interest in intellectual property protections, patent violations from global trading partners, and prize funds that might reward inventors in the US making their inventions available more readily.

“If you think of healthcare reform as a law that was passed and is now being implemented, that would be inaccuarate,” he said. “It is a law that is being refined, rules being written, changes likely.”

 

TAGGED:Deloitte Centerhealthcare reformpaul keckley
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Before Sterilization Begins: Why Bioburden Testing Matters -- AI-generated illustration
Before Sterilization Begins: Why Bioburden Testing Matters
Health Infographics
September 11, 2026
Hidden Cybersecurity Roadblocks That Can Complicate FDA Submissions -- AI-generated illustration
Hidden Cybersecurity Roadblocks That Can Complicate FDA Submissions
Infographics Policy & Law Technology
September 11, 2026
Smaller, Lighter, Smarter: How Inflation Is Changing Wellness Packaging -- AI-generated illustration
Smaller, Lighter, Smarter: How Inflation Is Changing Wellness Packaging
Infographics Wellness
September 11, 2026
How Roof Deterioration Affects Indoor Air Quality and the Health of Building Occupants -- AI-generated illustration
How Roof Deterioration Affects Indoor Air Quality and the Health of Building Occupants
Health
September 10, 2026

You Might also Like

URAC Accredited IRO
Business

The Value of a URAC Accredited IRO

August 27, 2015

Words to Avoid in Your Medical Marketing Communication

December 20, 2014

Games Health Plans Play: Understanding 2015 Obamacare Premiums

June 20, 2014

Only 18 percent of Hospital CEO’s are Women

February 4, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?